The contractor shall adapt an HIV-1 TAT inhibition assay from DR. Susana valente of the scripps research institute, florida to an HTS platform. An HTS campaign shall be conducted to identify compounds…
Ended Awarded Last action
- Contract number
- 75N93019F00135
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $499,682
Award facts
- Contract value 100% obligated
- $499,682.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $499,682 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit research organization. The contract is valued at $499,682.00 and has a completion date of November 30, 2020.
Under this contract, Southern Research is tasked with adapting an existing HIV-1 Tat inhibition assay to a high-throughput screening (HTS) platform and conducting an HTS campaign to identify compounds that can inhibit the action of the HIV-1 Tat protein. This work supports the NIH's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. Southern Research has extensive experience providing drug discovery and development services, as well as research on emerging infectious diseases, for various government agencies and partners.
The contract does not have a set-aside designation.
Description
The contractor shall adapt an HIV-1 TAT inhibition assay from DR. Susana valente of the scripps research institute, florida to an HTS platform. An HTS campaign shall be conducted to identify compounds that inhibit the action of HIV-1 TAT. The contrac
Quick answers
Who was awarded contract 75N93019F00135?
75N93019F00135 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2019.
How much is contract 75N93019F00135 worth?
The government has obligated $499,682 on 75N93019F00135.
Is contract 75N93019F00135 an order under another contract?
Yes. 75N93019F00135 is a delivery order under HHSN272201400010I, an indefinite delivery contract.
Was contract 75N93019F00135 competed?
The extent of competition for 75N93019F00135 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award